← Every company

Revelation Biosciences Inc SEC Filings

What Revelation Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

REVB overview →
Filings on file
106
since Jul 29, 2020
Warning signs
15
latest Jan 7, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 6, 2026
Results announced
8-K
Read ↗
May 7, 2026
Results announced
8-K
Read ↗
Feb 26, 2026
Results announced
8-K
Read ↗
Nov 6, 2025
Results announced
8-K
Read ↗
Aug 8, 2025
Results announced
8-K
Read ↗
May 8, 2025
Results announced
8-K
Read ↗
Mar 6, 2025
Results announced
8-K
Read ↗
Nov 8, 2024
Results announced
8-K
Read ↗
Aug 9, 2024
Results announced
8-K
Read ↗
May 10, 2024
Results announced
8-K
Read ↗
Mar 22, 2024
Results announced
8-K
Read ↗
Nov 13, 2023
Results announced
8-K
Read ↗
Aug 11, 2023
Results announced
8-K
Read ↗
May 22, 2023
Results announced
8-K
Read ↗
Apr 3, 2023
Results announced
8-K
Read ↗
Nov 10, 2022
Results announced
8-K
Read ↗
Aug 17, 2022
Results announced
8-K
Read ↗
May 17, 2022
Results announced
8-K
Read ↗

Source: Revelation Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on REVB

Related datasets